» Articles » PMID: 30977463

Infections Caused by Group C and G Streptococcus ( Subsp. and Others): Epidemiological and Clinical Aspects

Overview
Specialty Microbiology
Date 2019 Apr 13
PMID 30977463
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococci carrying serogroup C and G antigens, and in particular, subsp. (SDSE), are emerging human pathogens that are increasingly isolated from patients with a myriad of infections that range from mundane to life-threatening. SDSE is microbiologically similar to . These streptococci frequently cause infections of the throat and skin and soft tissues. Moreover, they may invade the bloodstream and disseminate widely to many deep tissue sites, including the endocardium. Life-threatening invasive infections due to SDSE, including the streptococcal toxic shock syndrome, occur most frequently in patients with severe underlying medical diseases. Treatment with penicillin is adequate under most circumstances, but treatment failure occurs. SDSE may also be resistant to other antibiotic classes including tetracyclines, macrolides, and clindamycin. Most human infections caused by groups C and G streptococci are transmitted from person to person, but infections due to subsp. (and, rarely, to subsp. ) are zoonoses. Transmission of these latter species occurs by animal contact or by contamination of food products and has been associated with the development of poststreptococcal glomerulonephritis. Members of the group, usually classified with the viridans group of streptococci, are associated with a variety of pyogenic infections.

Citing Articles

Genetic analysis reveals the genetic diversity and zoonotic potential of Streptococcus dysgalactiae isolates from sheep.

Stefanska I, Kwiecien E, Didkowska A, Kizerwetter-Swida M, Chrobak-Chmiel D, Salamaszynska-Guz A Sci Rep. 2025; 15(1):3165.

PMID: 39863800 PMC: 11763030. DOI: 10.1038/s41598-025-87781-3.


A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system.

He K, Zhao K, Yin T, Liu M, Liu J, Du W Sci Rep. 2025; 15(1):2346.

PMID: 39824966 PMC: 11742032. DOI: 10.1038/s41598-025-86976-y.


in the development and treatment of precancerous lesions of gastric cancer.

Qian S, Zhao H, Xie F, Liu Q, Cai D World J Gastrointest Oncol. 2024; 16(9):3771-3780.

PMID: 39350992 PMC: 11438778. DOI: 10.4251/wjgo.v16.i9.3771.


Streptococcal Toxic Shock Syndrome with Multiple Cerebral Infarctions Caused by Streptococcus dysgalactiae subsp. equisimilis: An Autopsy Case Report.

Saito S, Taniuchi N, Motoda N, Tsunoda K, Sato J, Suzuki T Intern Med. 2024; 64(3):469-475.

PMID: 38960691 PMC: 11867761. DOI: 10.2169/internalmedicine.3640-24.


Repeated Hemolytic Streptococcal Infections in Soft Tissue Eosinophilic Granulomatosis (Kimura's Disease): A Case Report.

Togawa M, Ikeda T, Konishi K, Ichibayashi R Cureus. 2024; 16(4):e57811.

PMID: 38721217 PMC: 11077614. DOI: 10.7759/cureus.57811.


References
1.
Turner J, Hayden F, Lobo M, Ramirez C, Murren D . Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students. J Clin Microbiol. 1997; 35(1):1-4. PMC: 229503. DOI: 10.1128/jcm.35.1.1-4.1997. View

2.
Facklam R . What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002; 15(4):613-30. PMC: 126867. DOI: 10.1128/CMR.15.4.613-630.2002. View

3.
Megged O, Assous M, Weinberg G, Schlesinger Y . Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae. Isr Med Assoc J. 2013; 15(1):27-30. View

4.
Balter S, Benin A, Pinto S, Teixeira L, Alvim G, Luna E . Epidemic nephritis in Nova Serrana, Brazil. Lancet. 2000; 355(9217):1776-80. DOI: 10.1016/s0140-6736(00)02265-0. View

5.
Tee W, Lieu P, Ngan C . Epidemiology of beta-haemolytic group G streptococcal bacteraemia in Singapore (1996 to 1998). Ann Acad Med Singap. 2002; 31(1):86-91. View